PolySense
Itamar Medical , Ltd. · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for PolySense, a 510(k) submitted by Itamar Medical, Ltd. of Caesarea, Israel, under number K260648. The decision date is 30 October 2026, and the application was received 27 February 2026. The device falls under regulation 882.1835 with classification product code GWL and subsequent product code DSH; the regulation medical specialty and review panel are both listed as Neurology. The record describes the submission type as Traditional, with no third-party review, no combination product designation and no authorized predetermined change control plan.
Substantially equivalent in this 510(k) context denotes marketing clearance rather than premarket approval. The public record identifies the device classification name as Amplifier, Physiological Signal, but does not describe the specific components, design changes or performance data supporting the equivalence determination. The corresponding FDA summary document is not included in the available material, so the basis for the decision and any comparison device remain unknown.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260648
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Itamar Medical , Ltd.
- Product code
- GWL
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Amplifier, Physiological Signal.
- Applicant
- Itamar Medical , Ltd.
- Product code
- GWL
- FDA device class
- 2
FDA decision timeline
K260648 received
Application receipt date recorded by FDA.
K260648 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Itamar Medical , Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Caesarea
Sources and methodology
- Original FDA record: K260648
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records